Untitled record

A composition that is isotonic with respect to humans and / or is lyophilized composition comprising a combination of two or more antigens GBS, wherein said combination includes: i) GBS 80 comprising the amino acid sequence of SEQ ID N .º 2 or an immunogenic fragment thereof or a polypeptide sequence having sequence identity 80% or greater with the same; and ii) at least one of GBS 91 comprising the amino acid sequence of SEQ ID NO: 11, an immunogenic fragment thereof or a polypeptide sequence having sequence identity 80% or more thereto, GBS 104 comprises the amino acid sequence of SEQ ID NO: 19, an immunogenic fragment thereof or a polypeptide sequence having sequence identity 80% or more thereto, GBS 184 comprising the amino acid sequence of SEQ ID N. No. 24, an immunogenic fragment thereof or a polypeptide sequence having sequence identity 80% or more thereto, GBS 276 comprising the amino acid sequence of SEQ ID NO: 27, an immunogenic fragment thereof or a polypeptide sequence having sequence identity 80% or more thereto, GBS 305 comprising the amino acid sequence of SEQ ID NO: 32, an immunogenic fragment thereof or a polypeptide sequence having sequence identity 80 % or higher thereto, GBS 322 comprising the amino acid sequence of SEQ ID NO: 37, an immunogenic fragment thereof or a polypeptide sequence having sequence identity 80% or more thereto, GBS 330 comprises the amino acid sequence of SEQ ID NO: 40, an immunogenic fragment thereof or a polypeptide sequence having sequence identity 80% or more thereto, GBS 338 comprising the amino acid sequence of SEQ ID N. No. 42, an immunogenic fragment thereof or a polypeptide sequence having sequence identity 80% or more thereto, GBS 361 comprising the amino acid sequence of SEQ ID NO: 45, an immunogenic fragment thereof or a polypeptide sequence having sequence identity 80% or more thereto, GBS 404 comprising the amino acid sequence of SEQ ID NO: 48, an immunogenic fragment thereof or a polypeptide sequence having sequence identity 80 % or higher thereto, GBS 690 comprising the amino acid sequence of SEQ ID NO: 50, an immunogenic fragment thereof or a polypeptide sequence having sequence identity 80% or more thereto, GBS 691 that It comprises the amino acid sequence of SEQ ID NO: 53, an immunogenic fragment thereof or a polypeptide sequence having sequence identity 80% or greater with the same.